LARA Diagnostics AB develops NEQST™ – a handheld medical device for quick, easy and quantitative assessment and screening of diabetes peripheral nerve injury (DPN). We aim to modernize and quantify nerve diagnostics to improve screening, monitoring and decision support for an enhanced diabetes care.
Together with more than 50 healthcare professionals and researchers in Sweden, Norway, Denmark, Germany, England and the US, LARA Diagnostics has developed the first truly portable device for investigation of vibration and temperature thresholds. It is compatible with e-health and digital systems and can be applied to the whole healthcare chain to harmonize examinations.
Louise Warme, CEO, Lara Diagnostics, föreläser på Park Annual 16 ”A novel approach to assessment of peripheral nerve injury”.